A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab to help prepare for future biological threats using the company’s machine learning ...
Pharmaceutical and biotech companies on the hunt for new drugs run tests along the way to see how proteins interact. Analyzing protein-protein interaction can reveal how cells communicate, the way ...
SAN FRANCISCO and SEATTLE, April 02, 2026 (GLOBE NEWSWIRE)-- Tamarind Bio, an AI platform providing access to state-of-the-art computational biology tools, and A-Alpha Bio, a synthetic biology and ...
What do you get when you combine a revolutionary healthcare startup with artificial intelligence (AI) technology? In the case of A-Alpha Bio, the answer is simple: a $22.4 million funding round and a ...
As a graduate student in the lab of protein design expert David Baker, PhD, at the University of Washington, David Younger, PhD, noticed a major bottleneck to designing massive amounts of proteins in ...
SEATTLE, Sept. 23, 2025 (GLOBE NEWSWIRE) -- A-Alpha Bio, a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions, today ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A-Alpha Bio is working with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results